Table 1A.
Study sample characteristics.
| Sample Characteristics of the Two Cohorts | ||||
|---|---|---|---|---|
| FHS (N=1227) | FHS Women (N=683) | FHS Men (N=544) | MrOS (N=836) | |
| Male, n (%) | 544 (44.3) | 0 (0) | 544 (100) | 836 (100) |
| Age, years (S.D) | 55.2 (9.1) | 54.8 (8.9) | 55.6 (9.2) | 84.2 (4.0) |
| Smoking, n (%) | 77 (6.3) | 41 (6.0) | 36 (6.6) | 10 (1.2) |
| BMI, Kg/m2 (S.D) | 28.0 (5.5) | 27.2 (5.9) | 29.0 (4.8) | 27.0 (3.8) |
| Diabetes, n (%) | 107 (8.7) | 42 (6.1) | 65 (11.9) | 133 (15.9) |
| Recent Hospitalization, n (%) | 85 (6.9) | 51 (7.5) | 34 (6.3) | 168 (20.1) |
| Use of Proton Pump Inhibitor, n (%) | 146 (11.9) | 79 (11.6) | 67 (12.3) | 184 (22.0) |
| Use of Metformin, n (%) | 80 (6.5) | 35 (5.1) | 45 (8.3) | 59 (7.1) |
| Total number of Medications (S.D) | 2.7 (3.0) | 2.9 (3.2) | 2.3 (2.8) | 9.1 (5.6) |
| Revised Diet Quality Index (S.D) | 74.2 (9.7) | 75.3 (9.7) | 72.7 (9.6) | 50.1 (13.6) |
| Race, n (%) | ||||
| African American | 16 (1.3) | 8 (1.2) | 8 (1.5) | 27 (3.2) |
| Asian | 34 (2.8) | 18 (2.6) | 16 (2.9) | 30 (3.6) |
| Hispanic | 21 (1.7) | 10 (1.5) | 11 (2.0) | 18 (2.2) |
| White | 1119 (91.2) | 620 (90.8) | 499 (91.7) | 748 (89.5) |
| Other | 37 (3.0) | 27 (4.0) | 10 (1.8) | 13 (1.6) |
The FHS cohort participants is comprised of both men and women as broken down in the table, while the MrOS cohort participants is comprised of only men. All sample characteristics differed between the two cohorts (p<0.05) except for the use of metformin. In the comparison of FHS Men and FHS Women, there were no statistical difference in age, smoking, hospitalization, use of proton pump inhibitors, and race. The comparison of FHS Men and MrOS showed that there were no significant difference in the use of metformin, and race.